Russell Investments Group
NAUT icon

Russell Investments Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Russell Investments Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.43K Buy
+3,976
New +$10.5K ﹤0.01% 3987
2025
Q2 		– Sell
-178
Closed -$153 – 3924
2025
Q1 		$153 Buy
+178
New +$265 ﹤0.01% 3741
2024
Q4 		– Sell
-167
Closed -$476 – 3761
2024
Q3 		$476 Buy
+167
New +$432 ﹤0.01% 3578

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Russell Investments Group's NAUT Position: Q2 2026 in Review

Russell Investments Group opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 3,976 shares worth $7.43K. The stake represents ﹤0.01% of the portfolio and ranks #3987 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in NAUT as recently as Q1 2025.

Russell Investments Group first reported a position in NAUT in Q3 2024 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Russell Investments Group held 3,976 shares of Nautilus Biotechnolgy worth $7.43K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Russell Investments Group position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3987 holding.
  • Russell Investments Group first reported a position in Nautilus Biotechnolgy in Q3 2024 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.